Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.

Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K, Ishizuka S, Sato N, Saruwatari K, Saeki S, Tomita Y, Sakagami T.

J Clin Med. 2019 May 29;8(6). pii: E762. doi: 10.3390/jcm8060762.

2.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

3.

Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin.

Kakiuchi Y, Sakata S, Nakamura K, Okabayashi H, Akaike K, Tokunaga T, Saeki S, Fujii K, Ichiyasu H.

Intern Med. 2019 May 1;58(9):1329-1333. doi: 10.2169/internalmedicine.1446-18. Epub 2019 Jan 10.

4.

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K.

Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020.

PMID:
30396984
5.

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.

Ishizuka S, Sakata S, Yoshida C, Takaki A, Saeki S, Nakamura K, Fujii K.

Respir Investig. 2018 Jul;56(4):361-364. doi: 10.1016/j.resinv.2018.03.005. Epub 2018 May 10.

PMID:
29764752
6.

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

Sakata S, Matsuoka Y, Kawahara K, Kakiuchi Y, Takaki A, Hirosue A, Yoshida R, Saeki S, Fujii K, Nakayama H.

Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.

PMID:
29548660
7.

Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation.

Sakata S, Sakamoto Y, Takaki A, Ishizuka S, Saeki S, Fujii K.

Intern Med. 2018 Aug 1;57(15):2223-2226. doi: 10.2169/internalmedicine.9612-17. Epub 2018 Mar 9.

8.

Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.

Sakata S, Saeki S, Sato R, Ishizuka S, Sasaki J, Fujii K.

Respir Investig. 2017 Nov;55(6):372-375. doi: 10.1016/j.resinv.2017.08.005. Epub 2017 Oct 6.

PMID:
29153418
9.

A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma.

Sakata S, Saeki S, Terasaki Y, Natori Y, Fujii K.

Intern Med. 2018 Mar 1;57(5):721-724. doi: 10.2169/internalmedicine.9300-17. Epub 2017 Nov 20.

10.

Small-cell Lung Cancer Associated with SAPHO Syndrome.

Imamura K, Sakata S, Sakamoto Y, Saeki S.

Intern Med. 2018 Jan 1;57(1):149-151. doi: 10.2169/internalmedicine.9162-17. Epub 2017 Oct 16. No abstract available.

11.

Pneumothorax in a Patient with Unilateral Pulmonary Artery Agenesis.

Anai M, Sakata S, Kishi H, Yatsunami K.

Intern Med. 2018 Jan 1;57(1):145-147. doi: 10.2169/internalmedicine.9093-17. Epub 2017 Oct 16. No abstract available.

12.

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non-small cell lung cancer harboring EGFR mutations.

Tanaka K, Nosaki K, Otsubo K, Azuma K, Sakata S, Ouchi H, Morinaga R, Wataya H, Fujii A, Nakagaki N, Tsuruta N, Takeshita M, Iwama E, Harada T, Nakanishi Y, Okamoto I.

Oncotarget. 2017 Jul 12;8(40):68123-68130. doi: 10.18632/oncotarget.19243. eCollection 2017 Sep 15.

13.

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Otsubo K, Nosaki K, Imamura CK, Ogata H, Fujita A, Sakata S, Hirai F, Toyokawa G, Iwama E, Harada T, Seto T, Takenoyama M, Ozeki T, Mushiroda T, Inada M, Kishimoto J, Tsuchihashi K, Suina K, Nagano O, Saya H, Nakanishi Y, Okamoto I.

Cancer Sci. 2017 Sep;108(9):1843-1849. doi: 10.1111/cas.13309. Epub 2017 Jul 26.

14.

Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.

Sakata S, Saeki S, Okamoto I, Otsubo K, Komiya K, Morinaga R, Yoneshima Y, Koga Y, Enokizu A, Kishi H, Hirosako S, Yamaguchi E, Aragane N, Fujii S, Harada T, Iwama E, Semba H, Nakanishi Y, Kohrogi H.

Lung Cancer. 2016 Sep;99:41-5. doi: 10.1016/j.lungcan.2016.06.009. Epub 2016 Jun 14.

PMID:
27565912
15.

Primary Diaphragmatic Dedifferentiated Liposarcoma in a Young Female Patient after Delivery.

Sakata S, Yoshida C, Saeki S, Hirosako S, Ichiyasu H, Kohrogi H.

Case Rep Oncol Med. 2016;2016:4042719. doi: 10.1155/2016/4042719. Epub 2016 May 10.

16.

[II. Development and Future Prospects of the Third-Generation EGFR-Tyrosine Kinase Inhibitor].

Sakata S, Iwama E, Okamoto I.

Gan To Kagaku Ryoho. 2015 Aug;42(8):935-9. Japanese. No abstract available.

PMID:
26353390
17.

A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab.

Sakata S, Saeki S, Hirooka S, Hirosako S, Ichiyasu H, Kohrogi H.

Case Rep Oncol Med. 2015;2015:842621. doi: 10.1155/2015/842621. Epub 2015 May 13.

18.

Dose escalation and pharmacokinetic study of carboplatin plus pemetrexed for elderly patients with advanced nonsquamous non-small-cell lung cancer: Kumamoto thoracic oncology study group trial 1002.

Sakata S, Sasaki J, Saeki S, Hamada A, Kishi H, Nakamura K, Tanaka H, Notsute D, Sato R, Saruwatari K, Iriki T, Akaike K, Fujii S, Hirosako S, Kohrogi H.

Oncology. 2015;88(4):201-7. doi: 10.1159/000369255. Epub 2014 Dec 6.

PMID:
25502447
19.

Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases.

Ichiyasu H, Horio Y, Tsumura S, Hirosako S, Sakamoto Y, Sakata S, Nakashima K, Komatsu T, Kojima K, Masunaga A, Fujii K, Saita N, Kohrogi H.

Mod Rheumatol. 2014 Mar;24(2):361-5. doi: 10.3109/14397595.2013.852847.

PMID:
24593215
20.

Psb28 is involved in recovery of photosystem II at high temperature in Synechocystis sp. PCC 6803.

Sakata S, Mizusawa N, Kubota-Kawai H, Sakurai I, Wada H.

Biochim Biophys Acta. 2013 Jan;1827(1):50-9. doi: 10.1016/j.bbabio.2012.10.004. Epub 2012 Oct 16.

Supplemental Content

Loading ...
Support Center